Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine therapy for "nonfunctioning" pituitary tumors

D G Johnston, K Hall, A McGregor

    The American Journal of Medicine
    |December 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Biopsychosocial factors and low back pain in military personnel with lower limb loss: the ADVANCE study.

    BMJ military health·2025
    Same author

    From the clinic to the wards, the evolution of penicillin allergy testing by non-allergists in a UK hospital.

    The Journal of hospital infection·2024
    Same author

    Diabetes mellitus is not a predictor of poor TB treatment outcomes.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
    Same author

    A laboratory Brucella exposure in a UK hospital: a Swiss cheese model?

    The Journal of hospital infection·2019
    Same author

    Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains.

    Journal of neurodegenerative diseases·2015
    Same author

    Hypertriglyceridaemic waist phenotype as a simple predictive marker of incident diabetes in Asian-Indian men with prediabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2014
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Bromocriptine may effectively treat recurrent nonsecretory pituitary tumors when surgery or radiotherapy fail. This study shows bromocriptine therapy can shrink these difficult-to-treat tumors.

    Area of Science:

    • Endocrinology
    • Neurosurgery
    • Oncology

    Background:

    • Nonsecretory pituitary tumors lack effective treatment options beyond surgery and radiotherapy.
    • Recurrences after conventional treatments for these tumors present a significant therapeutic challenge.

    Observation:

    • A patient with a recurrent nonsecretory pituitary tumor, previously treated with surgery and radiotherapy, experienced rapid regrowth.
    • The patient was subsequently treated with bromocriptine (20 mg daily) for 25 months.

    Findings:

    • Bromocriptine therapy led to a significant reduction in the size of the intrasellar tumor recurrence.
    • A suprasellar extension of the tumor almost completely disappeared during bromocriptine treatment.

    Implications:

    Related Experiment Videos

    • Bromocriptine may be a viable therapeutic option for patients with nonsecretory pituitary tumors unsuitable for surgery or radiotherapy.
    • This finding suggests a potential role for bromocriptine in managing recurrent or refractory nonsecretory pituitary adenomas.